Bionano Genomics (BNGO) PT Lowered to $2 at Maxim Group
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BNGO Hot Sheet
Price: $1.19 --0%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 2
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 2
Join SI Premium – FREE
Maxim Group analyst Jason McCarthy lowered the price target on Bionano Genomics (NASDAQ: BNGO) to $2.00 (from $3.00) while maintaining a Buy rating.
You May Also Be Interested In
- BioNano Genomics, Inc. (BNGO) files $400M mixed shelf
- SolarEdge (SEDG) PT Lowered to $31 at Susquehanna
- Trimble Navigation (TRMB) PT Lowered to $73 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
